Decitabine activates type I interferon signaling to inhibit p53‐deficient myeloid malignant cells
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-11-01
|
| Series: | Clinical and Translational Medicine |
| Online Access: | https://doi.org/10.1002/ctm2.593 |
| _version_ | 1831707968982220800 |
|---|---|
| author | Jiale Wu Yuntong Li Jiaqi Wu Huaxin Song Yigang Tang Ni Yan Lili Wu Sujiang Zhang ChunKang Chang Min Lu |
| author_facet | Jiale Wu Yuntong Li Jiaqi Wu Huaxin Song Yigang Tang Ni Yan Lili Wu Sujiang Zhang ChunKang Chang Min Lu |
| author_sort | Jiale Wu |
| collection | DOAJ |
| first_indexed | 2024-12-20T21:49:06Z |
| format | Article |
| id | doaj.art-926e064d1d464ddf9ab10186d85b09c2 |
| institution | Directory Open Access Journal |
| issn | 2001-1326 |
| language | English |
| last_indexed | 2024-12-20T21:49:06Z |
| publishDate | 2021-11-01 |
| publisher | Wiley |
| record_format | Article |
| series | Clinical and Translational Medicine |
| spelling | doaj.art-926e064d1d464ddf9ab10186d85b09c22022-12-21T19:25:36ZengWileyClinical and Translational Medicine2001-13262021-11-011111n/an/a10.1002/ctm2.593Decitabine activates type I interferon signaling to inhibit p53‐deficient myeloid malignant cellsJiale Wu0Yuntong Li1Jiaqi Wu2Huaxin Song3Yigang Tang4Ni Yan5Lili Wu6Sujiang Zhang7ChunKang Chang8Min Lu9State Key Laboratory of Medical Genomics National Research Center for Translational Medicine (Shanghai) Shanghai Institute of Hematology Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai ChinaState Key Laboratory of Medical Genomics National Research Center for Translational Medicine (Shanghai) Shanghai Institute of Hematology Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai ChinaState Key Laboratory of Medical Genomics National Research Center for Translational Medicine (Shanghai) Shanghai Institute of Hematology Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai ChinaState Key Laboratory of Medical Genomics National Research Center for Translational Medicine (Shanghai) Shanghai Institute of Hematology Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai ChinaState Key Laboratory of Medical Genomics National Research Center for Translational Medicine (Shanghai) Shanghai Institute of Hematology Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai ChinaState Key Laboratory of Medical Genomics National Research Center for Translational Medicine (Shanghai) Shanghai Institute of Hematology Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai ChinaState Key Laboratory of Medical Genomics National Research Center for Translational Medicine (Shanghai) Shanghai Institute of Hematology Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai ChinaState Key Laboratory of Medical Genomics National Research Center for Translational Medicine (Shanghai) Shanghai Institute of Hematology Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai ChinaDepartment of Hematology Shanghai Institute of Hematology Shanghai Jiao Tong University Affiliated Sixth People's Hospital Shanghai ChinaState Key Laboratory of Medical Genomics National Research Center for Translational Medicine (Shanghai) Shanghai Institute of Hematology Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai Chinahttps://doi.org/10.1002/ctm2.593 |
| spellingShingle | Jiale Wu Yuntong Li Jiaqi Wu Huaxin Song Yigang Tang Ni Yan Lili Wu Sujiang Zhang ChunKang Chang Min Lu Decitabine activates type I interferon signaling to inhibit p53‐deficient myeloid malignant cells Clinical and Translational Medicine |
| title | Decitabine activates type I interferon signaling to inhibit p53‐deficient myeloid malignant cells |
| title_full | Decitabine activates type I interferon signaling to inhibit p53‐deficient myeloid malignant cells |
| title_fullStr | Decitabine activates type I interferon signaling to inhibit p53‐deficient myeloid malignant cells |
| title_full_unstemmed | Decitabine activates type I interferon signaling to inhibit p53‐deficient myeloid malignant cells |
| title_short | Decitabine activates type I interferon signaling to inhibit p53‐deficient myeloid malignant cells |
| title_sort | decitabine activates type i interferon signaling to inhibit p53 deficient myeloid malignant cells |
| url | https://doi.org/10.1002/ctm2.593 |
| work_keys_str_mv | AT jialewu decitabineactivatestypeiinterferonsignalingtoinhibitp53deficientmyeloidmalignantcells AT yuntongli decitabineactivatestypeiinterferonsignalingtoinhibitp53deficientmyeloidmalignantcells AT jiaqiwu decitabineactivatestypeiinterferonsignalingtoinhibitp53deficientmyeloidmalignantcells AT huaxinsong decitabineactivatestypeiinterferonsignalingtoinhibitp53deficientmyeloidmalignantcells AT yigangtang decitabineactivatestypeiinterferonsignalingtoinhibitp53deficientmyeloidmalignantcells AT niyan decitabineactivatestypeiinterferonsignalingtoinhibitp53deficientmyeloidmalignantcells AT liliwu decitabineactivatestypeiinterferonsignalingtoinhibitp53deficientmyeloidmalignantcells AT sujiangzhang decitabineactivatestypeiinterferonsignalingtoinhibitp53deficientmyeloidmalignantcells AT chunkangchang decitabineactivatestypeiinterferonsignalingtoinhibitp53deficientmyeloidmalignantcells AT minlu decitabineactivatestypeiinterferonsignalingtoinhibitp53deficientmyeloidmalignantcells |